Skip to content
10-Q

Quarterly Report

US-China Biomedical Technology, Inc.

0001683168-19-000057

← back to feed
Filed
Jan 10, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Jan 10, 2019 15.51M sh
Operating Cash Flow Q3 2019 · Nov 30, 2018 −$369.73K
Operating Cash Flow Q3 2019 · Nov 30, 2017 −$223.03K
Stockholders Equity Q3 2019 · Nov 30, 2018 $175.39K
Stockholders Equity Q3 2019 · Feb 28, 2018 −$271.81K
Total Liabilities Q3 2019 · Nov 30, 2018 $63.93K
Total Liabilities Q3 2019 · Feb 28, 2018 $352.43K
Current Assets Q3 2019 · Nov 30, 2018 $220.1K
Current Assets Q3 2019 · Feb 28, 2018 $61.41K
Total Assets Q3 2019 · Nov 30, 2018 $239.32K
Total Assets Q3 2019 · Feb 28, 2018 $80.63K
Sga Expense Q3 2019 · Nov 30, 2018 $119.35K
Sga Expense Q3 2019 · Nov 30, 2018 $348.91K
Sga Expense Q3 2019 · Nov 30, 2017 $128.97K
Sga Expense Q3 2019 · Nov 30, 2017 $398.88K
Net Income Q3 2019 · Nov 30, 2018 −$119.35K
Net Income Q3 2019 · Nov 30, 2018 −$536.96K
Net Income Q3 2019 · Nov 30, 2017 −$131.55K
Net Income Q3 2019 · Nov 30, 2017 −$406.47K
Operating Income Q3 2019 · Nov 30, 2018 −$119.35K
Operating Income Q3 2019 · Nov 30, 2018 −$348.91K
Operating Income Q3 2019 · Nov 30, 2017 −$128.97K
Operating Income Q3 2019 · Nov 30, 2017 −$398.88K